Canadian life sciences leaders come together to deliberate recommendations with the Federal government

by • October 25, 2018 • Feature Slider, Feature-Home, Featured-Slides-HomeComments Off on Canadian life sciences leaders come together to deliberate recommendations with the Federal government229

Three exemplary organizations in Canada are hosting an event to advance the Canadian health and biosciences sector to build and encourage action and agreement that will boost recommendations from the Government of Canada’s Canada’s Health and Biosciences Economic Strategy Table Report.

The Centre for Drug Research and Development (CDRD), TRIUMF Innovations and BIOTECanada along with the Honourable Navdeep Singh Bains will be in attendance to discuss the importance of life science sector investment and Canada’s long-term vision for its Health and Biosciences industry.

The Report provides five recommendations on how to accelerate the growth of the Canadian Life Sciences industry with the goal of becoming a global health and biosciences hub:

  1. Accelerate Innovation Adoption
  2. Design Agile Regulations
  3. Harness Technology
  4. Develop & Attract Talent
  5. Create Anchor Firms

The event will follow LifeScience BC’s 2018 Investor Summit, and is designed to foster discussion, and catalyze collaborative efforts between government, industry, and not-for-profit organizations central to Canada’s research, innovation, and technology ecosystem.

 “The Health & Biosciences Economic Strategy table (HBEST) report and recommendations are both important and timely,” says Andrew Casey, president and CEO BIOTECanada. “The Canadian industry is presently in a growth phase with a number of companies moving closer to commercial reality and several other early-stage companies also showing great promise. The HBEST study recognizes the core strengths of Canada’s biotech sector and provides clear recommendations on how to build on these strengths and address key gaps with an aim to establishing high-value companies and ultimately create Canadian-based, globally competitive anchor companies.”

Event Details

Date: Thursday, October 25, 2018

Time: 3:30pm to 5.30pm

Location: Fairmont Pacific Rim, 1038 Canada Place, Vancouver

Speaking Program

  • Welcome Remarks – Gordon McCauley, President & CEO, CDRD
  • Fireside Chat
    • Moderator: Dr. Alan Winter Innovation Commissioner Province of BC
    • Hon. Navdeep Bains, Minister of Innovation, Science and Economic Development
    • Karimah Es Sabar, CEO & Partner, Quark Ventures & Chair, Health and Biosciences Economic Strategy Table
  • Panel Discussion              
    • Chair: Andrew Casey, President & CEO, BIOTECanada
    • Norma Biln, CEO & Co-Founder, Augurex
    • Jennifer Chan, Vice-President, Merck Canada
    • Karimah Es Sabar, CEO & Partner, Quark Ventures & Chair, Health and Biosciences Economic Strategy Table
  • Panel Thank You – Kathryn Hayashi, President & CEO, TRIUMF Innovations
  • Closing Comments & Thank You    
    • Daniel Hetu, Managing Director, Lumira Ventures
    • Dr. Lesley Esford, President & CEO, LifeSciences BC

“As a research powerhouse, Canada has the potential to become a global leader in life sciences, but we must do more to create strong Canadian companies of scale,” says Gordon C. McCauley, president and CEO, CDRD. “The federal government has taken important steps to support the growth of the sector, and we as the members of Canada’s life sciences ecosystem must support the Health and Biosciences Economic Strategy Table’s recommendations, and work together in building productive partnerships, aligning our objectives, sharing our knowledge and resources, and collaborating on mutually beneficial projects. CDRD has already initiated such collaborations with national and international partners with unwavering focus on our shared Vision of Canadian life sciences leading the world.”

Comments are closed.